Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer; Chemotherapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT06282796
What this trial is testing

Early Prediction and Warning for Cardiotoxicity Due to Anthracycline-Based Breast Cancer Chemotherapy

Who this might be right for
Breast Cancer
First Hospital of China Medical University 600
Not applicableUnknownNCT05728788
What this trial is testing

Correlation Between Myocardial Injury and Intestinal Flora Changes Associated With Oncology Drug Therapy

Who this might be right for
Cancer Therapy-related Cardiovascular Toxicity
Peking University Third Hospital 50
Early research (Phase 1)Study completedNCT02222688
What this trial is testing

UC-961 (Cirmtuzumab) in Relapsed or Refractory Chronic Lymphocytic Leukemia

Who this might be right for
Chronic Lymphocytic Leukemia
Thomas Kipps 26
Testing effectiveness (Phase 2)Looking for participantsNCT07339488
What this trial is testing

Intestinal Low-Dose Radiotherapy Plus Immunochemotherapy for Conversion of Borderline Resectable/Unresectable Esophageal Squamous Cell Carcinoma

Who this might be right for
Borderline Resectable CarcinomaUnresectable CancerEsophageal Squamous Cell Carcinoma (ESCC)+4 more
Chuangzhen Chen 43
Testing effectiveness (Phase 2)Study completedNCT01205503
What this trial is testing

Trial of Mesna to Prevent Doxorubicin-induced Plasma Protein Oxidation and Tumor Necrosis Factor Alpha (TNF-α) Release

Who this might be right for
Breast CancerNon-Hodgkin's Lymphoma
Mara Chambers 32
Large-scale testing (Phase 3)Looking for participantsNCT06598527
What this trial is testing

Stereotactic Body Radiotherapy Followed by Tislelizumab Plus Platinum-based Chemotherapy Versus Tislelizumab Plus Platinum-based Chemotherapy as Neoadjuvant Therapy in Patients With Resectable Stage Ⅱ-Ⅲ Non-small Cell Lung Cancer: A Phase Ⅲ, Randomized, Multicenter, Prospective Study

Who this might be right for
Lung Cancer (NSCLC)
Yang Hong 360
Testing effectiveness (Phase 2)Study completedNCT02315768
What this trial is testing

Ibrutinib in Combination With GA101 (Obinutuzumab) in Previously Untreated Chronic Lymphocytic Leukemia (CLL) Patients.

Who this might be right for
Chronic Lymphocytic Leukemia
University of California, San Diego 32
Not applicableActive Not RecruitingNCT04472910
What this trial is testing

GATA6 Expression as a Predictor of Response to Peri-Operative Chemotherapy in Resectable Pancreatic Adenocarcinoma

Who this might be right for
Resectable Pancreatic Cancer
University Health Network, Toronto 84
Large-scale testing (Phase 3)Study completedNCT00003013
What this trial is testing

Chemotherapy Plus Surgery in Treating Women With Breast Cancer

Who this might be right for
Breast Cancer
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 450
Testing effectiveness (Phase 2)Study completedNCT00799513
What this trial is testing

Trial on Lenalidomide Given as Maintenance Therapy for Relapsed Diffuse Large B Cell Lymphoma

Who this might be right for
Diffuse Large B-cell Lymphoma
IRCCS San Raffaele 48
Not applicableLooking for participantsNCT05834413
What this trial is testing

Clinical Study on the Prevention of Driver Gene Negative Ib-IIIb Lung Cancer Recurrence and Metastasis by Staged Chinese Herbal Medicine Combined With Chemotherapy and Immune Checkpoint Inhibitors

Who this might be right for
Lung Cancer
Shanghai University of Traditional Chinese Medicine 367
Testing effectiveness (Phase 2)WithdrawnNCT06522360
What this trial is testing

Brigatinib Plus Chemotherapy or Local Consolidation Therapy in ALK Positive Advanced Non-small Cell Lung Cancer (BrightStar-2)

Who this might be right for
Non-small Cell Lung Cancer
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Ended earlyNCT04964960
What this trial is testing

Pembro+Chemo in Brain Mets

Who this might be right for
Lung CancerLung Cancer MetastaticBrain Cancer+1 more
John L. Villano, MD, PhD 3
Testing effectiveness (Phase 2)Looking for participantsNCT04421820
What this trial is testing

BOLD-100 in Combination With FOLFOX for the Treatment of Advanced Solid Tumours

Who this might be right for
Colorectal CancerPancreatic CancerGastric Cancers+1 more
Bold Therapeutics, Inc. 220
Not applicableLooking for participantsNCT05189496
What this trial is testing

Hyperbaric Oxygen in the Prevention of Radiation Pneumonitis

Who this might be right for
Radiation Pneumonitis
Guangdong Provincial People's Hospital 380
Early research (Phase 1)Study completedNCT00005946
What this trial is testing

Chemotherapy Plus Donor White Blood Cell Infusion in Treating Patients With Relapsed Hematologic Cancer Following Donor Peripheral Stem Cell Transplantation

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more
University of Maryland, Baltimore
Not applicableStudy completedNCT04045561
What this trial is testing

Development of a Standardized Reference Guide for Tuning Adherence to Dispense During a Initial Pharmaceutical Consulting (CP ) to the Patient With Multiple Myeloma Oral Chemotherapy Primocure

Who this might be right for
Multiple Myeloma
Centre Hospitalier Universitaire de Nīmes 10
Early research (Phase 1)Ended earlyNCT00955942
What this trial is testing

Flaxseed Supplement in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Undergoing Chemotherapy and Radiation Therapy

Who this might be right for
Lung CancerRadiation Toxicity
Abramson Cancer Center at Penn Medicine 48
Testing effectiveness (Phase 2)UnknownNCT02983942
What this trial is testing

Ketogenic Diet Adjunctive to HD-MTX Chemotherapy for Primary Central Nervous System Lymphoma

Who this might be right for
Primary Central Nervous System Lymphoma
Beijing Tiantan Hospital 50
Testing effectiveness (Phase 2)Study completedNCT05807542
What this trial is testing

Neoadjuvant Immunotherapy Combined With Chemotherapy in Patients With Locally Advanced ESCC

Who this might be right for
Esophagus Cancer
Shanghai Zhongshan Hospital 20
Next Page